Table 3.

Factors that influence post-EBRT positive biopsy rate.

	All studies	Consistent with 2020 NCCN guidelines	Consistent with 2020 NCCN guidelines, no ADT	Consistent with 2020 NCCN guidelines + short-term ADT	Mandated biopsy	Mandated biopsy and managed to biopsy ≥70% of all patients	Exclusively low- to intermediate-risk patients	Exclusively high-risk patients
No. of studies	22	9	5	3	15	4	11	5
No. of patients	3067	832	349	241	2450	798	1567	357
Positive biopsy rate (95% CI)	32% (25–39)	22% (19–41)	34% (23–50)	14% (3.8–31)	35% (21–38)	47% (5–63)	25% (15–32)	29% (20–46)